2024-09-03 - Analysis Report
## PFE Stock Analysis:

**Company:** Pfizer Inc., a global pharmaceutical company specializing in the research, development, and manufacture of medicines and vaccines.

**1. Performance vs. S&P 500 (VOO):**

* PFE's cumulative return is -26.27%, while VOO's is 89.66%.
* This represents a significant underperformance of -115.93%, meaning PFE has performed 115.93% worse than the S&P 500. 
* The Relative Divergence of -115.93 is at its minimum, indicating PFE is at a historical low point compared to the S&P 500.

**2. Recent Price Action:**

* **Closing Price:** $29.01
* **5-Day Moving Average:** $28.84
* **20-Day Moving Average:** $28.85
* **60-Day Moving Average:** $28.80

The stock is currently trading slightly above its 5-day and 20-day moving averages, suggesting potential for short-term upward movement.

**3. Technical Indicators:**

* **RSI:** 60.69, indicating the stock is neither overbought nor oversold.
* **PPO:** -0.02, suggests a weak short-term momentum.
* **Delta_Previous_Relative_Divergence:** -11.82, indicating a recent short-term decline in relative performance.
* **Expected Return:** 0.0%, implying limited potential for growth over the next 5 years.

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-07-30 | 0.6 | 0.458 |
| 2024-05-01 | 0.82 | 0.516 |
| 2024-01-30 | 0.1 | -0.19 |
| 2023-10-31 | -0.17 | -0.32 |
| 2023-08-01 | 0.67 | 0.56 |

Pfizer has consistently beaten earnings estimates in recent quarters, with the exception of the last quarter, where it fell short of estimates. This suggests a potential for future growth, but it remains to be seen if this trend will continue.

**5. Overall Analysis:**

PFE has significantly underperformed the broader market in recent years, with its relative performance at a historical low point. While recent earnings have been positive, the stock's technical indicators suggest a lack of short-term momentum and limited growth potential. 

**6.  Recommendations:**

Given the current market conditions and the company's performance, a cautious approach is recommended. Investors should monitor PFE's future earnings releases and overall market trends before making any investment decisions. 

**Disclaimer:** This analysis is for informational purposes only and should not be considered financial advice. Always consult with a qualified financial professional before making any investment decisions. 
